Mainz Biomed N.V (MYNZ) Operating Margin: 2022-2023
Historic Operating Margin for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to -3,068.71%.
- Mainz Biomed N.V's Operating Margin rose 127159.00% to -3,068.71% in Q4 2023 from the same period last year, while for Dec 2023 it was -2,975.47%, marking a year-over-year increase of 201513.00%. This contributed to the annual value of -2,091.23% for FY2024, which is 88424.00% up from last year.
- According to the latest figures from Q4 2023, Mainz Biomed N.V's Operating Margin is -3,068.71%, which was up 1.17% from -3,104.90% recorded in Q3 2023.
- In the past 5 years, Mainz Biomed N.V's Operating Margin registered a high of -2,593.94% during Q1 2023, and its lowest value of -5,657.13% during Q3 2022.
- For the 2-year period, Mainz Biomed N.V's Operating Margin averaged around -4,067.33%, with its median value being -3,762.09% (2023).
- Data for Mainz Biomed N.V's Operating Margin shows a peak YoY soared of 300,598bps (in 2023) over the last 5 years.
- Mainz Biomed N.V's Operating Margin (Quarterly) stood at -4,340.30% in 2022, then spiked by 127,159bps to -3,068.71% in 2023.
- Its Operating Margin stands at -3,068.71% for Q4 2023, versus -3,104.90% for Q3 2023 and -3,183.87% for Q2 2023.